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We  thank  Dr.  Baranchuk  and  colleagues  for  their  thoughtful  and  insightful  comments 
regarding  our  manuscript.                                            
While the primary focus of the manuscript was repolarization abnormalities we regretfully did 
not  cite  the  authors  important  work  on  ECG  fragmentation.  Unfortunately,  the  authors' 
abstract [1,2] was not noted in our initial literature search.  The authors subsequently reported 
their  data in manuscript form [3] in January of 2014.  This should serve as a reminder to 
consider a repeat literature review after an initial manuscript is submitted, as failing to do so 
can  lead  to  an  incomplete  review when new data  becomes  available  in  the  interim.      
An important point is raised regarding the lack of association seen between fragmentation and 
appropriate shocks in the FECHA study. [1,3]  Fragmentation may be an indicator of scar 
presence,  but perhaps not directly  related to arrhythmia risk.  The FECHA study provides 
important insight, but should be interpreted in context, as the patient population studied was 
high risk (70% secondary prevention indication for ICD).  Therefore, fragmentation may not 
be expected to be an independent risk factor for appropriate ICD therapy given the appropriate 
therapy  rates  in  a  secondary  prevention  population.  Further,  the  increased  use  of  beta-
blockers in the fragmented QRS group may have decreased the differences between groups.  
In  our  manuscript  we found increased  fragmentation  in  the  Chagas  Disease  patients  with 
cardiomyopathy  relative  to  their  non-ischemic  cardiomyopathy  counterparts,  as  well  as 
increased  fragmentation  in  Chagas  Disease  patients  with  normal  ejection  fraction,  but 
conduction  system  involvement,  when  compared  to  controls.  Fragmentation  was  not  a 
predictor of death or transplant as a univariate variable in our study.  Fragmentation in our 
patient  population  will  be  reassessed  in  a  larger  cohort  with  MRI  correlation  in  future 
studies.   
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We believe that scar burden should predict severity of disease and arrhythmia risk, and there is 
precedence  for  this  in  the  Chagas  Disease  population.  [4-6]  However,  patients  with  non-
ischemic cardiomyopathy, while often having delayed enhancement on cardiac MRI and low 
voltage on electroanatomic mapping during electrophysiologic study, tend to have arrhythmia 
burden out of proportion to the burden of documented scar.  This may be due to microfibrosis 
as the authors point out.  Another potential explanation may be the occurrence of functional 
ventricular arrhythmias in this population, as opposed to reentrant arrhythmias involving large 
scars  described  in  an  ischemic  cardiomyopathy  population.  The  involvement  of  the 
autonomic nervous system, and the destruction of said system, in Chagas Disease may also be 
a  potential  contributing  factor  to  the  increased  ventricular  arrhythmia  risk  in  this  patient 
population  and  requires  further  study.                                    
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